Through Genomics to Mechanisms research, our vision is to deliver state-of-the-art treatments to 6 million Barts Health NHS Trust patients.
Cardiovascular research programmes at the WHRI and the Barts Heart Centre are closely aligned to maximise our collective expertise and strengths in areas such as pharmacological and device development that lead to innovative clinical trials for the diagnosis and treatment of heart disease whilst offering a range of professional training opportunities. Combined, our strategic approach enables the development and delivery of world-leading clinical care.
Genomics of Rare and Complex CV Traits (CAD, BP, Heart rhythm, Rare) - 100,000 Genomes Project, UK Biobank & International Mouse Phenotyping ConsortiumLead researchers: Deloukas, Munroe, Brown, Caulfield, Kelsell, Tinker, Barnes, Smedley, Petersen
Cardiac Inflammation & Immunology - Humanitas PartnershipLead researchers: Marelli-Berg, Nourshargh, Rot, Mantovani, Chen
Cardiovascular Disease TherapeuticsLead researchers: Ahluwalia, Hobbs, Thiemermann, Brown, Xiao, Caulfield, Aksentijevic, Chen
Device-Based and Imaging Based Innovation - EU Devices Centre/Yale PartnershipLead researchers: Mathur, Lansky, Baumbach, Krams, Petersen
Stratified medicine and innovative trials - NICORLead researchers: Brown, Caulfield, Deanfield
Stem cell researchLead researchers: Mathur, Suzuki
Advanced Cardiovascular ImagingLead researcher: Steffen Petersen
Therapeutic Innovation and PharmacologyLead researcher: Aksentijevic
We have strong links to the Barts Health NHS Trust Cardiovascular Clinical Academic Group and University College (UCL) Institute of CV Sciences, UCL Heart Hospital and UCL Partners Integrated Cardiovascular System connecting bench to the clinic.
Our key partners include: